
Devyser Diagnostics Investor Relations Material
Latest events

Q2 2025
Devyser Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Devyser Diagnostics
Access all reports
Devyser Diagnostics AB is a Swedish company that develops, manufactures, and sells advanced diagnostic kits for DNA testing. Their products are primarily used in the fields of hereditary diseases, oncology, and post-transplantation monitoring. These diagnostic solutions enable laboratories to conduct complex genetic tests, including those for cancer treatments, prenatal screening, and transplant patient follow-ups. The company also provides software tools for data analysis and interpretation to support their test kits. The company is headquartered in Stockholm, Sweden, and its shares are traded on the Nasdaq Stockholm.
Key slides for Devyser Diagnostics


Q2 2025
Devyser Diagnostics


Q1 2025
Devyser Diagnostics
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
DVYSR
Country
🇸🇪 Sweden